Literature DB >> 19631835

[Implications of the REACH registry for vascular surgery].

Luis Javier Alvarez-Fernández1, Manuel Javier Vallina-Victorero Vázquez, María José Ramos Gallo, María Vicente Santiago.   

Abstract

Because of the increase in life expectancy, peripheral artery disease (PAD) has become a major health problem. A study performed in Spain in persons aged more than 65 years old found an overall prevalence of PAD of 9.9%. The most important risk factors for PAD were smoking, diabetes mellitus, advanced age, hyperlipidemia and hypertension. Treatment includes smoking cessation, exercise, statins, platelet antiaggregants, cilostazol or hemorheologic agents, and revascularization techniques. Data from the Spanish arm of REACH indicate that the PAD subgroup shows the poorest control of blood pressure and cholesterol and that use of platelet antiaggregants and statins is lowest in these patients, indicating that therapeutic and preventive strategies are not being correctly applied.

Entities:  

Mesh:

Year:  2009        PMID: 19631835     DOI: 10.1016/S0025-7753(09)71749-X

Source DB:  PubMed          Journal:  Med Clin (Barc)        ISSN: 0025-7753            Impact factor:   1.725


  1 in total

1.  Practice-based evidence: profiling the safety of cilostazol by text-mining of clinical notes.

Authors:  Nicholas J Leeper; Anna Bauer-Mehren; Srinivasan V Iyer; Paea Lependu; Cliff Olson; Nigam H Shah
Journal:  PLoS One       Date:  2013-05-23       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.